EXEL EXELIXIS, INC.
Nasdaq · SEC CIK 939767 · EDGAR
- Bought, last 12 months
- $1.19M 1 purchases by 1 insiders
- Sold, last 12 months
- $42.24M 24 sales by 12 insiders
- Filings on record
- 313 since 2021-07-08, latest 2026-08-12 19:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Aftab Dana | EVP, Research, Development | — | $7.70M |
| Haley Patrick J. | EVP, Commercial | — | $7.60M |
| Smith Julie | Dir | — | $4.69M |
| WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| Senner Christopher J. | EVP, CFO | — | $4.56M |
| PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| POSTE GEORGE | Dir | — | $2.74M |
| Beckerle Mary C | Dir | — | $1.93M |
| Oliver Bob | Dir | — | $1.33M |
| Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Transactions 443
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-05 | 2023-04-03 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +79.7K | 332.6K | +32% | $0 | |
| D | 2023-03-14 | 2023-03-10 | EXEL | WYSZOMIERSKI JACK L | Dir | S - Sale+OE | $16.61 | -15.3K | 317.5K | -5% | -$254.1K |
| D | 2023-03-14 | 2023-03-10 | EXEL | WYSZOMIERSKI JACK L | Dir | M - OptEx | $6.30 | +40.0K | 332.8K | +14% | +$252.0K |
| D | 2023-03-03 | 2023-03-01 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | M - OptEx | $14.74 | +27.9K | 605.6K | +5% | +$410.7K |
| D | 2023-03-03 | 2023-03-01 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale+OE | $17.13 | -77.9K | 527.7K | -13% | -$1.33M |
| DM | 2023-03-01 | 2023-02-27+ | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | M - OptEx | $14.74 | +82.5K | 434.0K | +23% | +$1.22M |
| DM | 2023-03-01 | 2023-02-27+ | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale+OE | $17.50 | -82.5K | 351.5K | -19% | -$1.44M |
| D | 2023-02-23 | 2023-02-21 | EXEL | Garber Alan M | Dir | S - Sale+OE | $17.49 | -40.0K | 31.4K | -56% | -$699.6K |
| D | 2023-02-23 | 2023-02-21 | EXEL | Garber Alan M | Dir | M - OptEx | $6.30 | +40.0K | 71.4K | +127% | +$252.0K |
| 2023-02-17 | 2023-02-15 | EXEL | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | F - Tax | $18.08 | -17.3K | 225.1K | -7% | -$312.8K | |
| 2023-02-17 | 2023-02-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $18.08 | -5,278 | 504.7K | -1% | -$95.4K | |
| 2023-02-17 | 2023-02-15 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $18.08 | -1,929 | 577.7K | -0.3% | -$34.9K | |
| 2023-02-17 | 2023-02-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $18.08 | -1,556 | 252.9K | -0.6% | -$28.1K | |
| 2023-02-17 | 2023-02-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $18.08 | -11.5K | 329.1K | -3% | -$208.3K | |
| 2023-02-17 | 2023-02-15 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $18.08 | -1,529 | 351.5K | -0.4% | -$27.6K | |
| D | 2023-02-10 | 2023-02-09 | EXEL | FELDBAUM CARL B | Dir | S - Sale+OE | $17.78 | -40.0K | 18.7K | -68% | -$711.2K |
| D | 2023-02-10 | 2023-02-09 | EXEL | FELDBAUM CARL B | Dir | M - OptEx | $6.30 | +40.0K | 58.7K | +214% | +$252.0K |
| D | 2023-02-08 | 2023-02-06 | EXEL | Haley Patrick J. | EVP, Commercial | M - OptEx | $4.20 | +25.0K | 279.4K | +10% | +$105.0K |
| D | 2023-02-08 | 2023-02-06 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale+OE | $17.37 | -25.0K | 254.4K | -9% | -$434.2K |
| 2023-02-01 | 2023-01-30 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -38.0K | 340.7K | -10% | $0 | |
| I | 2023-02-01 | 2023-01-30 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | +38.0K | 1.34M | +3% | $0 |
| D | 2023-01-26 | 2022-12-07 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -106.0K | 340.7K | -24% | $0 |
| D | 2023-01-26 | 2023-01-24 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $17.36 | -62.0K | 378.6K | -14% | -$1.08M |
| D | 2023-01-26 | 2023-01-24 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | M - OptEx | $4.20 | +100.0K | 440.7K | +29% | +$420.0K |
| DI | 2023-01-26 | 2022-12-07 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | +106.0K | 1.30M | +9% | $0 |
| 2023-01-09 | 2023-01-05 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +100.0K | 353.0K | +40% | $0 | |
| D | 2022-12-16 | 2022-12-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | M - OptEx | $4.20 | +20.0K | 431.0K | +5% | +$84.0K |
| D | 2022-12-16 | 2022-12-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | S - Sale+OE | $15.88 | -20.0K | 411.0K | -5% | -$317.6K |
| D | 2022-12-01 | 2022-11-29 | EXEL | POSTE GEORGE | Dir | S - Sale+OE | $16.68 | -40.0K | 193.2K | -17% | -$667.2K |
| D | 2022-12-01 | 2022-11-29 | EXEL | POSTE GEORGE | Dir | M - OptEx | $6.30 | +40.0K | 233.2K | +21% | +$252.0K |
| 2022-11-17 | 2022-11-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | F - Tax | $16.71 | -7,177 | 411.0K | -2% | -$119.9K | |
| 2022-11-17 | 2022-11-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $16.71 | -7,177 | 254.4K | -3% | -$119.9K | |
| 2022-11-17 | 2022-11-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $16.71 | -8,074 | 509.9K | -2% | -$134.9K | |
| 2022-11-17 | 2022-11-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $16.71 | -23.3K | 446.7K | -5% | -$389.4K | |
| M | 2022-11-17 | 2021-05-17+ | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale | $22.73 | -36.0K | 586.8K | -6% | -$818.3K |
| 2022-11-17 | 2022-11-15 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $16.71 | -7,177 | 579.6K | -1% | -$119.9K | |
| D | 2022-09-14 | 2022-09-12 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale+OE | $17.94 | -40.0K | 261.6K | -13% | -$717.6K |
| D | 2022-09-14 | 2022-09-12 | EXEL | Haley Patrick J. | EVP, Commercial | M - OptEx | $6.21 | +40.0K | 301.6K | +15% | +$248.4K |
| D | 2022-08-12 | 2022-08-11 | EXEL | Senner Christopher J. | EVP, CFO | M - OptEx | $6.21 | +225.0K | 670.9K | +50% | +$1.40M |
| D | 2022-08-12 | 2022-08-11 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $19.23 | -152.9K | 518.0K | -23% | -$2.94M |
| 2022-08-05 | 2022-08-03 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $21.49 | -8,074 | 445.9K | -2% | -$173.5K | |
| 2022-08-05 | 2022-08-03 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +32.6K | 454.0K | +8% | $0 | |
| 2022-08-05 | 2022-08-03 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +28.9K | 268.8K | +12% | $0 | |
| 2022-08-05 | 2022-08-03 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $21.49 | -7,177 | 261.6K | -3% | -$154.2K | |
| 2022-08-05 | 2022-08-03 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +94.0K | 493.3K | +24% | $0 | |
| 2022-08-05 | 2022-08-03 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $21.49 | -23.3K | 470.0K | -5% | -$500.8K | |
| 2022-08-05 | 2022-08-03 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | A - Grant | $0.00 | +28.9K | 425.3K | +7% | $0 | |
| 2022-08-05 | 2022-08-03 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | F - Tax | $21.49 | -7,177 | 418.1K | -2% | -$154.2K | |
| 2022-08-05 | 2022-08-03 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | A - Grant | $0.00 | +28.9K | 630.0K | +5% | $0 | |
| 2022-08-05 | 2022-08-03 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $21.49 | -7,177 | 622.8K | -1% | -$154.2K | |
| 2022-06-01 | 2022-05-27 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $18.21 | -18.8K | 239.8K | -7% | -$342.6K | |
| 2022-05-27 | 2022-05-26 | EXEL | Freire Maria C | Dir | A - Grant | $0.00 | +19.6K | 59.7K | +49% | $0 | |
| 2022-05-27 | 2022-05-26 | EXEL | WYSZOMIERSKI JACK L | Dir | A - Grant | $0.00 | +19.6K | 292.8K | +7% | $0 | |
| 2022-05-27 | 2022-05-26 | EXEL | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +19.6K | 1.24M | +2% | $0 | |
| D | 2022-05-27 | 2022-05-26 | EXEL | FELDBAUM CARL B | Dir | A - Grant | $0.00 | +10.2K | 18.7K | +119% | $0 |
| 2022-05-27 | 2022-05-26 | EXEL | MARCHESI VINCENT T | Dir | A - Grant | $0.00 | +19.6K | 94.0K | +26% | $0 | |
| D | 2022-05-27 | 2022-05-26 | EXEL | Wright Jacqueline | Dir | A - Grant | $0.00 | +10.2K | 31.0K | +49% | $0 |
| 2022-05-27 | 2022-05-26 | EXEL | POSTE GEORGE | Dir | A - Grant | $0.00 | +19.6K | 193.2K | +11% | $0 | |
| M | 2022-05-17 | 2022-05-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $20.08 | -11.7K | 266.0K | -4% | -$235.4K |
| 2022-05-17 | 2022-05-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $20.08 | -8,444 | 421.4K | -2% | -$169.6K | |
| 2022-05-17 | 2022-05-15 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $20.08 | -5,349 | 601.0K | -0.9% | -$107.4K | |
| 2022-05-17 | 2022-05-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | F - Tax | $20.08 | -6,123 | 396.4K | -2% | -$122.9K | |
| D | 2022-05-13 | 2022-05-12 | EXEL | WILLSEY LANCE | Dir | S - Sale+OE | $19.65 | -40.0K | 424.4K | -9% | -$786.0K |
| D | 2022-05-13 | 2022-05-12 | EXEL | WILLSEY LANCE | Dir | M - OptEx | $3.13 | +40.0K | 464.4K | +9% | +$125.2K |
| D | 2022-04-06 | 2022-04-04 | EXEL | WYSZOMIERSKI JACK L | Dir | M - OptEx | $3.13 | +40.0K | 279.9K | +17% | +$125.2K |
| D | 2022-04-06 | 2022-04-04 | EXEL | WYSZOMIERSKI JACK L | Dir | S - Sale+OE | $23.00 | -6,696 | 273.2K | -2% | -$154.0K |
| DM | 2022-04-04 | 2022-03-31+ | EXEL | Haley Patrick J. | EVP, Commercial | M - OptEx | $6.21 | +20.0K | 279.2K | +8% | +$124.2K |
| DM | 2022-04-04 | 2022-03-31+ | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale+OE | $22.71 | -20.0K | 269.2K | -7% | -$454.3K |
| M | 2022-03-30 | 2022-03-28+ | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale | $22.00 | -18.0K | 618.5K | -3% | -$396.0K |
| 2022-03-08 | 2022-03-04 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | A - Grant | $0.00 | +67.9K | 623.2K | +12% | $0 | |
| 2022-03-08 | 2022-03-04 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +70.7K | 269.2K | +36% | $0 | |
| 2022-03-08 | 2022-03-04 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +76.0K | 429.8K | +21% | $0 | |
| 2022-03-08 | 2022-03-04 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +270.4K | 399.3K | +210% | $0 | |
| I | 2022-03-08 | 2022-03-02 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -50.0K | 1.20M | -4% | $0 |
| 2022-03-08 | 2022-03-04 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | A - Grant | $0.00 | +59.5K | 402.5K | +17% | $0 | |
| D | 2022-03-03 | 2022-03-01 | EXEL | Garber Alan M | Dir | M - OptEx | $3.13 | +40.0K | 52.7K | +315% | +$125.2K |
| D | 2022-03-03 | 2022-03-01 | EXEL | Garber Alan M | Dir | S - Sale+OE | $21.00 | -21.3K | 31.4K | -40% | -$447.3K |
| 2022-02-28 | 2022-02-25 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $19.53 | -31.2K | 198.5K | -14% | -$610.1K | |
| 2022-02-28 | 2022-02-24 | EXEL | Hessekiel Jeffrey | EVP, GC | S - Sale | $20.00 | -18.0K | 555.4K | -3% | -$360.0K | |
| D | 2022-02-24 | 2022-02-22 | EXEL | FELDBAUM CARL B | Dir | M - OptEx | $3.13 | +20.0K | 28.5K | +235% | +$62.6K |
| D | 2022-02-24 | 2022-02-22 | EXEL | FELDBAUM CARL B | Dir | S - Sale+OE | $19.49 | -20.0K | 8,521 | -70% | -$389.8K |
| 2022-02-24 | 2022-02-22 | EXEL | PAPADOPOULOS STELIOS | Dir | S - Sale | $19.56 | -84.5K | 1.22M | -6% | -$1.65M | |
| M | 2022-02-17 | 2022-02-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $18.59 | -18.3K | 353.8K | -5% | -$340.7K |
| M | 2022-02-17 | 2022-02-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $18.59 | -65.1K | 128.9K | -34% | -$1.21M |
| M | 2022-02-17 | 2022-02-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $18.59 | -15.5K | 229.7K | -6% | -$288.6K |
| M | 2022-02-17 | 2022-02-15 | EXEL | Hessekiel Jeffrey | EVP, GC | F - Tax | $18.59 | -12.2K | 573.4K | -2% | -$227.3K |
| M | 2022-02-17 | 2022-02-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | F - Tax | $18.59 | -20.2K | 343.0K | -6% | -$375.1K |
| D | 2022-02-04 | 2022-02-03 | EXEL | Haley Patrick J. | EVP, Commercial | M - OptEx | $1.90 | +60.0K | 305.2K | +24% | +$114.0K |
| D | 2022-02-04 | 2022-02-03 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale+OE | $17.91 | -60.0K | 245.2K | -20% | -$1.07M |
| 2022-01-06 | 2022-01-04 | EXEL | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | A - Grant | $0.00 | +250.0K | 250.0K | New | $0 | |
| 2022-01-06 | 2022-01-04 | EXEL | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | F - Tax | $19.18 | -7,613 | 242.4K | -3% | -$146.0K | |
| 2021-12-17 | 2021-12-15 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +19.5K | 377.3K | +5% | $0 | |
| 2021-12-17 | 2021-12-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $17.00 | -5,131 | 372.2K | -1% | -$87.2K | |
| D | 2021-12-17 | 2021-12-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | S - Sale+OE | $17.44 | -47.5K | 363.2K | -12% | -$828.4K |
| D | 2021-12-17 | 2021-12-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | M - OptEx | $6.21 | +47.5K | 410.7K | +13% | +$295.0K |
| D | 2021-12-17 | 2021-12-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | A - Grant | $0.00 | +18.7K | 367.8K | +5% | $0 |
| D | 2021-12-17 | 2021-12-15 | EXEL | Lamb Peter | EVP, CSO, Scientific Strategy | F - Tax | $17.00 | -4,646 | 363.2K | -1% | -$79.0K |
| 2021-12-17 | 2021-12-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $17.00 | -1,556 | 245.2K | -0.6% | -$26.5K | |
| 2021-12-17 | 2021-12-15 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +8,995 | 246.8K | +4% | $0 | |
| 2021-12-17 | 2021-11-29 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -196.5K | 170.8K | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations